Hey Team,
Here are some stats on the probability of success (PoS) for phase III trails between 2006 and 2015:
https://www.bio.org/sites/default/files/legacy/bioorg/docs/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf
And here is a distribution of those failures:
https://www.parexel.com/application/files_previous/5014/7274/5573/ACT_Article.pdf
I'd probably group CLBP under metabolic but I will let you pick what you want to group it under.
Keeping in mind a few things
- We know Remestemcel-L has a clean safety profile (as do almost all MSC therapies to date), so failure due to safety is extremely unlikely.
- We have passed two futility checks for Covid-19 ARDS, so there seems like there is some kind of efficacy signal
- We can also be pretty confident to rule out commercial failures due to the fact there is a significant unmet medical need and a poor standard of care
Collectively, this boosts the success stats a bit as failures due to efficacy are <60%. As such, it wouldn't be outrageous to half the failure rates demonstrated in the above table. The only real thing that could screw us for Covid-19 ARDS is the sample size, will we see efficacy by the final readout or will placebo do well/ our cells be insufficient to achieve significance.
Plenty of things give us a lot of confidence regarding efficacy, such as:
- The EAP with 10/12 survival.
- The UAE stem cell studies
- Athersys phase II data
- Similar pathophysiology to GvHD where I am satisfied that we have demonstrated efficacy.
- Two passes for futility checks.
However it's not all rosey, a big factor that reduces the PoS relative to the above figures is that:
- There has never been a commercially approved stem cell therapy
3000 deaths a day is a pretty damned good motivator to fix that though right?
- Forums
- ASX - By Stock
- MSB
- MSB Trading 2020 - a new dawn
MSB Trading 2020 - a new dawn, page-11993
-
-
- There are more pages in this discussion • 1,078 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B |
Open | High | Low | Value | Volume |
$1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 24758 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 73626 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10033 | 1.485 |
4 | 53700 | 1.480 |
1 | 770 | 1.475 |
3 | 62048 | 1.460 |
1 | 50000 | 1.455 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 21995 | 1 |
1.505 | 24000 | 1 |
1.510 | 13666 | 2 |
1.515 | 99798 | 1 |
1.520 | 27250 | 3 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |